Introduction
Can slowing the rate at which a child’s bones mature improve their final adult height? New research presented at ENDO 2026 suggests this may become an important area of future pediatric endocrinology research.For decades, most treatments aimed at improving a child’s adult height have focused on one simple goal—making children grow faster.
However, exciting new research presented at the Endocrine Society Annual Meeting (ENDO 2026) suggests that an equally important strategy may be to slow bone age progression, thereby allowing growth plates to remain open longer. Understanding Bone Age
Many parents focus only on their child’s height.
Pediatric endocrinologists know that another measurement is often just as important:
Bone Age
Bone age is determined by an X-ray of the left hand and wrist and reflects how mature the skeleton is compared with the child’s actual age.
For example:
- Chronological age: 10 years
- Bone age: 13 years
This means the skeleton is maturing much faster than expected.
Although these children may initially appear taller than their classmates, their growth plates often close earlier, resulting in reduced adult height.
Why Growth Plates Matter
Long bones grow through specialized cartilage called growth plates (epiphyseal plates).
Once these plates fuse:
- Growth hormone no longer increases height.
- Nutritional supplements cannot increase height.
- Exercise cannot reopen fused growth plates.
Therefore, preserving growth plate function during childhood is essential. What Is Crinecerfont?
Crinecerfont is a CRF1 receptor antagonist designed to reduce excessive ACTH stimulation of the adrenal glands.
Instead of simply increasing growth, the medication helps restore hormonal balance by:
- Reducing excess adrenal androgen production
- Allowing lower glucocorticoid doses
- Slowing bone age advancement
- Preserving remaining growth potential
What Did the New Study Show?
According to the Phase 3 CAHtalyst® Pediatric Study:
Children receiving crinecerfont demonstrated:
- Slower progression of bone age
- Better control of adrenal androgen excess
- Reduced glucocorticoid exposure
- Improvement in predicted adult height after two years of treatment
These findings support the concept that preserving growth potential may be just as important as stimulating growth.
A Shift in Modern Growth Medicine
Historically, pediatric endocrinology focused on one question:
“How can we make children grow faster?”
Modern research is increasingly asking a different question:
“How can we keep growth plates open for longer?”
This represents a major evolution in growth science.
Future therapies may combine:
Tissue engineering
Growth hormone
Hormonal optimization
Bone age management
Growth plate preservation
Genetic therapies
What This Research Means for Clinical Practice
While these findings are encouraging, it is important to understand that this research does not suggest that slowing bone age progression alone will increase adult height. Growth is influenced by multiple factors, including genetics, nutrition, hormonal balance, chronic medical conditions, and the health of the growth plates. Bone age progression is only one part of this complex process.
In clinical practice, the first step is a comprehensive medical evaluation rather than immediate treatment. Concerns about short stature or reduced growth velocity are typically assessed using serial height measurements, growth charts, bone age X-rays, family height patterns, and, when appropriate, laboratory investigations to evaluate hormonal or other underlying medical conditions. These findings help determine whether growth is within the normal range or whether further evaluation is warranted.
The concept of preserving growth plate function by slowing excessive skeletal maturation is particularly relevant in selected medical conditions where bone age advances more rapidly than chronological age. However, treatment decisions should always be individualized and based on established medical guidelines.
This emerging research highlights an important shift in thinking. Instead of focusing only on stimulating growth, future strategies may increasingly emphasize maintaining the health and longevity of the growth plate. As scientific knowledge advances, clinicians may be able to combine careful assessment, appropriate treatment when medically indicated, and long-term monitoring to optimize growth potential while maintaining patient safety. Continued research and well-designed clinical trials will be essential before these findings can be translated into routine clinical practice.
Dr. Vaibhav Patil’s Perspective
The most important message from this study is not that a new “height drug” has been discovered.
Rather, it reinforces a fundamental principle of pediatric growth:
Protecting the growth plate may be just as important as stimulating growth itself.
Understanding the causes of accelerated bone maturation allows doctors to intervene earlier in selected medical conditions and potentially improve final adult height.
As research continues, treatments are becoming increasingly precise, targeting the biological mechanisms that determine how long a person continues to grow. If you have concerns about your growth or bone age, a structured medical evaluation may help determine whether further investigations or treatment are appropriate.